Posts

Pancreatic Cancer • April 11, 2022, 5:48 p.m.

SARS-CoV-2: Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies

Scientists studied the sensitivity of Omicron BA.1 and BA.2 to nine monoclonal antibodies, some of which are used in pre-exposure prophylaxis in immunocompromised individuals. The scientists showed a loss of neutralizing activity against BA.1 and BA.2 in people treated with two antibody cocktails.

Mayur_Tembhare

Pancreatic Cancer • March 29, 2022, 7:22 p.m.

Distinct classes of fibroblasts in tumors play opposing roles, promoting or restraining pancreatic cancer growth

Pancreatic Cancer • March 23, 2022, 10:51 p.m.

Novel therapeutic strategy shows promise against pancreatic cancer

Pancreatic Cancer • March 8, 2022, 8:19 a.m.

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

Pancreatic Cancer • Feb. 26, 2022, 1:38 a.m.

Cancer: When viruses and bacteria cooperate

Pancreatic Cancer • Feb. 25, 2022, 2:12 a.m.

Pancreatic cancer: Cellular process suggests path to new treatment options

Trending

About Educracypedia

Educracypedia is a research news site that covers stories in the field of science and technology. The site is dedicated to providing accurate and up-to-date information on the latest scientific discoveries, and also offers opinion pieces on current affairs within the scientific community.

Navigation

© Copyright Educracypedia. All Rights Reserved

All Rights Reserved or by other parties, where indicated. All rights controlled by their respective owners. Content on this website is for information only. It is not intended to provide medical or other professional advice. || Views expressed here do not necessarily reflect those of Educracypedia, its staff, its contributors, or its partners. || Financial support for Educracypedia comes from advertisements and referral programs, where indicated.